Trump Bolsters U.S. Drug Supply With Ingredient Reserve
BOLSTERING PHARMACEUTICAL SECURITY: Today, President Donald J. Trump signed an Executive Order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with critical drug components, ensuring a resilient domestic supply chain for essential medicines.
ADDRESSING SUPPLY CHAIN VULNERABILITIES: Restoring capacity for domestic production of essential pharmaceutical products is essential to safeguarding national health and security against global supply chain disruptions.
RESTORING AMERICAN SELF-RELIANCE: President Trump has consistently prioritized policies to secure America’s pharmaceutical independence and ensure access to affordable, domestically produced drugs.
https://www.whitehouse.gov/fact-sheets/2025/08/fact-sheet-president-donald-j-trump-ensures-american-pharmaceutical-supply-chain-resilience-by-filling-the-strategic-active-pharmaceutical-ingredients-reserve/